Oncology Payables Turnover from 2010 to 2024

TOIIW Stock  USD 0.01  0  16.80%   
Oncology Institute Payables Turnover yearly trend continues to be fairly stable with very little volatility. Payables Turnover will likely drop to 12.19 in 2024. Payables Turnover is a liquidity ratio that shows how quickly The Oncology Institute pays off its suppliers by dividing total purchases by average accounts payable. View All Fundamentals
 
Payables Turnover  
First Reported
2010-12-31
Previous Quarter
18.34264329
Current Value
12.19
Quarterly Volatility
2.5626266
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Oncology Institute financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncology Institute's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.8 M, Interest Expense of 7.1 M or Selling General Administrative of 67.6 M, as well as many indicators such as Price To Sales Ratio of 0.44, Dividend Yield of 0.0235 or PTB Ratio of 2.51. Oncology financial statements analysis is a perfect complement when working with Oncology Institute Valuation or Volatility modules.
  
Check out the analysis of Oncology Institute Correlation against competitors.
For more information on how to buy Oncology Stock please use our How to Invest in Oncology Institute guide.

Latest Oncology Institute's Payables Turnover Growth Pattern

Below is the plot of the Payables Turnover of The Oncology Institute over the last few years. It is a liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable. Oncology Institute's Payables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oncology Institute's overall financial position and show how it may be relating to other accounts over time.
Payables Turnover10 Years Trend
Pretty Stable
   Payables Turnover   
       Timeline  

Oncology Payables Turnover Regression Statistics

Arithmetic Mean14.36
Geometric Mean14.17
Coefficient Of Variation17.84
Mean Deviation1.47
Median14.12
Standard Deviation2.56
Sample Variance6.57
Range10.9598
R-Value0.17
Mean Square Error6.88
R-Squared0.03
Significance0.55
Slope0.1
Total Sum of Squares91.94

Oncology Payables Turnover History

2024 12.19
2023 18.34
2022 21.38
2021 10.42
2020 11.91

About Oncology Institute Financial Statements

Oncology Institute investors use historical fundamental indicators, such as Oncology Institute's Payables Turnover, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Oncology Institute. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Payables Turnover 18.34  12.19 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Oncology Stock Analysis

When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.